EUVIMEDEUVIMED entdecken
Crossref

Chitosan nanoparticles of rutin mitigated histological changes induced in DNCB-induced colitis by enhanced modulation of inflammation and oxidative stress

Lokesh Nama, Rashmi Bhushan, Prakash Kumar, Somasundaram Arumugam, Om Prakash Ranjan, Prabhat Kumar, Nitesh Kumar

Journal of Molecular Histology · 2025

DOI: 10.1007/s10735-025-10491-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Histology, 2025. Verfasst von Lokesh Nama und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, Industrial Area Hajipur, Bihar, 8441…. Hauptthemen laut MEDLINE: Rutin, Chitosan, Oxidative Stress, Nanoparticles. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a chronic inflammatory illness of the colon involving increased production of reactive oxygen species (ROS) and involvement of inflammatory cytokinins. The present study aimed to alleviate colitis condition in rats by rutin-loaded chitosan nanoparticles for improving rutin's release profile, solubility, as well as targetability of inflammatory cells in the 2,4-Dinitrochlorobenzene (DNCB)-induced colitis model. This formulation contains chitosan polymer and an ionic crosslinking technique to create polymeric nanoparticles of rutin. The rats were grouped into five groups, with six in each group. The first group (normal control) consisted of rats fed a regular diet and water for 28 days. The second to fifth group of rats received DNCB (20 g/l 300 µl on nap every day for 14 days). Additionally, for 28 days, rutin (57 mg/kg/po/day) and chitosan-rutin nanoparticle (CRNPs) treatment (57 mg/kg/po.), respectively, in third and fourth-group rats, whereas standard medication sulfasalazine (100 mg/kg/po/day) for fifth group rats. DNCB administered in animals showed elevated ROS, Interlukin-6 (IL-6), and Tumor necrosis factor-α (TNF-α) levels compared to normal control. CRNPs showed a significant decrease in these parameters compared to the DNCB group. The protective effect of CRNPs against DNCB-induced inflammation was supported by histological assessment, where it prevented crypt destruction and immune cell infiltration. In conclusion, repeated administration of DNCB induces inflammation in the colon and bloody stool in rats. The current work was the first to show that CRNPs successfully reduced DNCB-induced IBD, possibly via lowering the level of oxidative stress (ROS) and proinflammatory cytokines (IL-6, TNF-α).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RutinChitosanOxidative StressNanoparticlesColitisInflammationAnimalsDinitrochlorobenzeneRatsMaleReactive Oxygen SpeciesDisease Models, AnimalRats, WistarColon

Stichwörter der Autor:innen

2,4-DinitrochlorobenzeneChitosan-rutin nanoparticlesInflammatory bowel diseaseInterleukin-6Tumor necrosis factor-α

Substanzen

RutinChitosanDinitrochlorobenzeneReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, Industrial Area Hajipur, Bihar, 844102, Vaishali, India.
  • Department of Biotechnology, National Institute of Pharmaceutical Education and Research, Hajipur, Industrial Area Hajipur, Bihar, 844102, Vaishali, India.
  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Kolkata, Chunilal Bhawan, 168, Maniktala Main Road, Kolkata, West Bengal, 700054, India.
  • Department of Pharmaceutical Technology (Formulations), National Institute of Pharmaceutical Education and Research, Guwahati, Kamrup, Assam, 781101, India.
  • Department of Pathology, Indira Gandhi Institute of Medical Sciences (IGIMS), Patna, Bihar, India.
  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Hajipur, Industrial Area Hajipur, Bihar, 844102, Vaishali, India. niteshkumar43@gmail.com.

Zitieren

APA

Nama, L., Bhushan, R., Kumar, P., Arumugam, S., Ranjan, O. P., Kumar, P., & Kumar, N. (2025). Chitosan nanoparticles of rutin mitigated histological changes induced in DNCB-induced colitis by enhanced modulation of inflammation and oxidative stress. Journal of Molecular Histology. https://doi.org/10.1007/s10735-025-10491-7

Vancouver

Nama L, Bhushan R, Kumar P, Arumugam S, Ranjan OP, Kumar P, et al. Chitosan nanoparticles of rutin mitigated histological changes induced in DNCB-induced colitis by enhanced modulation of inflammation and oxidative stress. Journal of Molecular Histology. 2025. doi:10.1007/s10735-025-10491-7

BibTeX
@article{Nama2025,
  author = {Nama, Lokesh and Bhushan, Rashmi and Kumar, Prakash and Arumugam, Somasundaram and Ranjan, Om Prakash and Kumar, Prabhat and Kumar, Nitesh},
  title = {Chitosan nanoparticles of rutin mitigated histological changes induced in DNCB-induced colitis by enhanced modulation of inflammation and oxidative stress},
  journal = {Journal of Molecular Histology},
  year = {2025},
  doi = {10.1007/s10735-025-10491-7}
}
Kostenlos starten →